Palantir Technologies (NYSE:PLTR) initially focused on serving the defense and intelligence sectors but has since expanded its customer base to include various industries such as healthcare, energy, and finance. The company has made impressive strides to improve profitability, and the new AI platform rolled out last year is accelerating top-line growth. As a result, there are
0 Comments
In this article BRK.A OXY Follow your favorite stocksCREATE FREE ACCOUNT Warren Buffett and Charlie Munger at press conference during the Berkshire Hathaway Shareholders Meeting in Omaha, Nebraska, April 30, 2022. CNBC Berkshire Hathaway‘s Warren Buffett said his sprawling conglomerate may only slightly outperform the average American company due to its sheer size and the
0 Comments
Warren Buffett ahead of the Berkshire Hathaway Annual Shareholder’s Meeting in Omaha, NE. David A. Grogan | CNBC Berkshire Hathaway on Saturday reported a big rise in operating earnings in the fourth quarter, thanks to huge gains in its insurance business, while its cash pile expanded to record levels. The Omaha-based conglomerate posted operating earnings
0 Comments
I like tracking Home Depot (NYSE:HD) stock given just how important housing is to the broader economy (and I like that they sell lumber!). That’s why its fourth-quarter earnings report is particularly interesting. Home Depot reported a decline in same-store sales of 3.5% in the fourth quarter of 2023, with a notable 4% decrease observed
0 Comments
As you may recall from my past coverage of Rivian Automotive (NASDAQ:RIVN), I’ve been bearish about this early-stage electric vehicle stock. However, following the EV maker’s latest quarterly earnings release, my RIVN stock analysis has become even more downbeat. Why? Admittedly, Rivian remains in a much better position than other high-profile EV upstarts. For instance,
0 Comments
Since the late 1970s, when the former options trader and arbitrageur moved into activist investing (then called “corporate raiding”), Carl Icahn has built a multi-billion dollar fortune investing in (and pushing for profitable changes at) undervalued companies. With this track record, it’s no surprise that Wall Street and Main Street investors alike are always curious
0 Comments
With new innovation, high demand for better treatment, pharmaceutical companies strengthening pipelines and a resurgence of mergers and acquisitions, biotech stocks could offer some of the most explosive opportunities of the year. “What’s more, big pharmaceutical companies with sizable piles of cash and the need to address patent expirations on some top-selling products later this
0 Comments
With the stock market reaching new record highs, the list of stocks to sell grows. Driven in part by expectations around artificial intelligence (AI) developments, several companies have become significantly overextended relative to their underlying financial performance. While broader economic and monetary conditions support ongoing gains across indices, not all firms will be wise long-term
0 Comments